IEEE/ACM Trans Comput Biol Bioinform. 2023 Nov-Dec;20(6):3411-3420. doi: 10.1109/TCBB.2022.3199244. Epub 2023 Dec 25.
Survival analysis is a significant study in cancer prognosis, and the multi-modal data, including histopathological images, genomic data, and clinical information, provides unprecedented opportunities for its development. However, because of the high dimensionality and the heterogeneity of histopathological images and genomic data, acquiring effective predictive characters from these multi-modal data has always been a challenge for survival analysis. In this article, we propose a transformer-based survival analysis model (TransSurv) for colorectal cancer that can effectively integrate intra-modality and inter-modality features of histopathological images, genomic data, and clinical information. Specifically, to integrate the intra-modality relationship of image patches, we develop a multi-scale histopathological features fusion transformer (MS-Trans). Furthermore, we provide a cross-modal fusion transformer based on cross attention for multi-scale pathological representation and multi-omics representation, which includes RNA-seq expression and copy number alteration (CNA). At the output layer of the TransSurv, we adopt the Cox layer to integrate multi-modal fusion representation with clinical information for end-to-end survival analysis. The experimental results on the Cancer Genome Atlas (TCGA) colorectal cancer cohort demonstrate that the proposed TransSurv outperforms the existing methods and improves the prognosis prediction of colorectal cancer.
生存分析是癌症预后研究中的一个重要分支,多模态数据,包括组织病理学图像、基因组数据和临床信息,为其发展提供了前所未有的机会。然而,由于组织病理学图像和基因组数据的高维度和异质性,从这些多模态数据中获取有效的预测特征一直是生存分析的挑战。在本文中,我们提出了一种基于 Transformer 的结直肠癌生存分析模型(TransSurv),可以有效地整合组织病理学图像、基因组数据和临床信息的模态内和模态间特征。具体来说,为了整合图像补丁的模态内关系,我们开发了一种多尺度组织病理学特征融合 Transformer(MS-Trans)。此外,我们提供了一种基于交叉注意力的跨模态融合 Transformer,用于多尺度病理表示和多组学表示,包括 RNA-seq 表达和拷贝数改变(CNA)。在 TransSurv 的输出层,我们采用 Cox 层将多模态融合表示与临床信息集成,用于端到端的生存分析。在癌症基因组图谱(TCGA)结直肠癌队列上的实验结果表明,所提出的 TransSurv 优于现有方法,并提高了结直肠癌的预后预测。